How many institutions own PBLA stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PBLA shares is 10, representing 0.16% of the company's common stock.

Who are the major shareholders selling Panbela Therapeutics, Inc. stock?

BANK OF AMERICA CORP /DE/, in the last quarter, reduced its stake in PBLA by -100% restricting it's holding to 0 shares of worth nearly -. WELLS FARGO & COMPANY/MN also lessened -100% of the PBLA shares from its portfolio, reducing its holding to 0 shares of worth -. VANGUARD GROUP INC also shunned PBLA shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying PBLA stock?

As per its latest 13F filing, UBS GROUP AG increased its stake in PBLA by 12.08% in the last quarter. The institutional holder raised its holding to 213.5 thousand shares having worth more than $14.95K. TWO SIGMA SECURITIES, LLC also added 100% more shares of PBLA to its portfolio, raising its holding to 66.17 thousand shares of worth $4.85K. RENAISSANCE TECHNOLOGIES LLC also increased its PBLA shares holding by 100% which brought its holding to 54.54 thousand shares worth $4.00K.

PBLA's major insiders: who are they?

The insider with the most stakes in PBLA is GOLDMAN SACHS GROUP INC , 10 percent owner at the company. Additionally, PBLA stock is highly held by director Schemel Donald Robert and director Cullen Michael T. among others.

Did an insider recently sell PBLA stock?

Company executives, directors, and other insiders own 0% percent of Panbela Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which PBLA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include GOLDMAN SACHS GROUP INC.

Which insider recently purchased PBLA stock?

There have been 0 transaction(s) during the past 6-months in which Panbela Therapeutics, Inc. insiders have bought stock, totalling 0 shares

How much of PBLA does insiders own?

Around 0 Panbela Therapeutics, Inc. shares are held by insiders, which represents about 0% of PBLA stock.

Who is the insider with the largest stake?

PBLA 10 percent owner, GOLDMAN SACHS GROUP INC holds the largest portfolio of the company's shares. PBLA shares owned by GOLDMAN total nearly 397.95 thousand.

Which institution holds the most shares in PBLA?

BANK OF AMERICA CORP /DE/ is the largest institutional owner in PBLA which holds 0 shares worth - or 0% of the total PBLA shares outstanding followed by WELLS FARGO & COMPANY/MN with ownership of 0 shares representing 0% of the PBLA ownership. VANGUARD GROUP INC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Panbela Therapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PBLA is concerned, it is a stock which is not optionable.

Is there a short position on PBLA's shares?

Number of PBLA shares short is 106.97K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding PBLA shares are there?

As of today, 4.85M shares of PBLA are outstanding.

Is there many float in PBLA stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PBLA has 4.85M shares in float.

PBLA short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PBLA is 0.07.

Panbela Therapeutics (PBLA) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableNo

Short Percent Of Outstanding Shares3.07

Short Percent Of Float3.07

Shares Outstanding4.85M

Shares Float4.85M

Shares Short106.97K

Short Ratio0.07

3.07%

Short % of Float

3.07%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0% Percentage of Shares held by All Insiders

0.16% Percentage of Shares held by All Institutions

0.16% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 0.16% of PBLA shares are held by financial institutions. BANK OF AMERICA CORP /DE/ is the top corporate investor, holding 0 shares valued at -. A 0% stake in Panbela Therapeutics, Inc. is owned by the company. WELLS FARGO & COMPANY/MN owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2023	BANK OF AMERICA CORP /DE/	0%	0	-	-2.86K	-100.00%
Mar 31, 2023	WELLS FARGO & COMPANY/MN	0%	0	-	-201	-100.00%
Mar 31, 2023	VANGUARD GROUP INC	0%	0	-	-20.61K	-100.00%
Mar 31, 2023	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	0	-	0	0
Mar 31, 2023	MORGAN STANLEY	0%	0	-	-32.5K	-100.00%
Mar 31, 2023	ROYAL BANK OF CANADA	0%	0	-	-500	-100.00%
Mar 31, 2023	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-54.54K	-100.00%
Mar 31, 2023	NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0%	0	-	-633	-100.00%
Mar 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-13.96K	-100.00%
Mar 31, 2023	OXFORD FINANCIAL GROUP LTD	0%	0	-	-20K	-100.00%
Mar 31, 2023	TWO SIGMA SECURITIES, LLC	0%	0	-	-66.17K	-100.00%
Mar 31, 2023	VERITION FUND MANAGEMENT LLC	0%	0	-	-20K	-100.00%
Mar 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-12.62K	-100.00%
Mar 31, 2023	CETERA ADVISOR NETWORKS LLC	0%	0	-	-22.66K	-100.00%
Mar 31, 2023	UBS GROUP AG	0%	0	-	-213.5K	-100.00%
Mar 31, 2023	ADVISOR GROUP HOLDINGS, INC.	0%	0	-	-3.12K	-100.00%
Dec 31, 2022	ARMISTICE CAPITAL, LLC	0%	0	-	-2.18M	-100.00%
Dec 31, 2022	UBS GROUP AG	0%	213.5K	14.95K	23.01K	+12.08%
Dec 31, 2022	TWO SIGMA SECURITIES, LLC	0%	66.17K	4.85K	66.17K	+100.00%
Dec 31, 2022	RENAISSANCE TECHNOLOGIES LLC	0%	54.54K	4K	54.54K	+100.00%
Dec 31, 2022	CETERA ADVISOR NETWORKS LLC	0%	22.66K	1.66K	22.66K	+100.00%
Dec 31, 2022	VANGUARD GROUP INC	0%	20.61K	1.51K	-201.7K	-90.73%
Dec 31, 2022	BANK OF AMERICA CORP /DE/	0%	2.86K	209	0	0
Dec 31, 2022	NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0%	633	46	633	+100.00%
Dec 31, 2022	GEODE CAPITAL MANAGEMENT, LLC	0%	13.96K	1K	0	0
Dec 31, 2022	MORGAN STANLEY	0%	32.5K	2.38K	-11.84K	-26.70%
Dec 31, 2022	OXFORD FINANCIAL GROUP LTD	0%	20K	1.47K	0	0
Dec 31, 2022	VERITION FUND MANAGEMENT LLC	0%	20K	1.46K	-1	-0.01%
Dec 31, 2022	TOWER RESEARCH CAPITAL LLC (TRC)	0%	12.62K	1K	-471	-3.60%
Dec 31, 2022	ROYAL BANK OF CANADA	0%	500	-	0	0
Dec 31, 2022	WELLS FARGO & COMPANY/MN	0%	201	15	201	+100.00%
Dec 31, 2022	BUCKINGHAM STRATEGIC WEALTH, LLC	0%	0	-	-24.93K	-100.00%
Dec 31, 2022	ADVISOR GROUP HOLDINGS, INC.	0%	0	-	-3.12K	-100.00%
Dec 31, 2022	BRAND ASSET MANAGEMENT GROUP, INC.	0%	0	-	-57.14K	-100.00%
Dec 31, 2022	CLEAR STREET LLC	0%	0	-	-110.5K	-100.00%
Dec 31, 2022	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	0	-	0	0
Dec 31, 2022	VIRTU FINANCIAL LLC	0%	0	-	-71.76K	-100.00%

Insiders

Among the PBLA insiders holding of 0% of the stake in company, GOLDMAN SACHS GROUP INC, 10 percent owner, holds the largest shares of 397.95K. SCHEMEL DONALD ROBERT, director, is the second largest PBLA insider with ownership of 300K shares. CULLEN MICHAEL T., director, stands third with possession of 247K shares of that stake.

Insiders	Designation	Shares Held
GOLDMAN SACHS GROUP INC	10 percent owner	397.95K
SCHEMEL DONALD ROBERT	director	300K
CULLEN MICHAEL T.	director	247K
SCHAFFER PAUL W.	director	159.42K
JACOB JEFFREY E.	director	49.5K
HORVATH SUSAN	V.P. of Finance & CFO	8.89K
SIMPSON JENNIFER K.	President and CEO	7.87K
FRATAMICO ARTHUR	director	2.42K
NANT CAPITAL, LLC	10 percent owner	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 15, 2024	NANT CAPITAL, LLC	PURCHASE	0.37	0	-	0
Nov 08, 2023	GOLDMAN SACHS GROUP INC	SALE	0.71	72.87K	51.74K	397.95K
Jan 30, 2023	SIMPSON JENNIFER K.	PURCHASE	2.25	4.44K	10K	7.87K
Jan 30, 2023	HORVATH SUSAN	PURCHASE	2.75	8.89K	24.44K	8.89K
Oct 04, 2022	CULLEN MICHAEL T.	PURCHASE	0.00	247K	-	247K
Oct 04, 2022	JACOB JEFFREY E.	PURCHASE	0.00	49.5K	-	49.5K
Oct 04, 2022	SCHEMEL DONALD ROBERT	PURCHASE	0.00	300K	-	300K
Sep 10, 2020	SIMPSON JENNIFER K.	PURCHASE	2.74	1K	2.74K	3.42K
Sep 08, 2020	SCHAFFER PAUL W.	PURCHASE	2.55	225	573.75	159.42K
Sep 04, 2020	SCHAFFER PAUL W.	PURCHASE	2.51	24.78K	62.16K	159.2K
Sep 01, 2020	FRATAMICO ARTHUR	PURCHASE	4.54	2.42K	11K	2.42K
Sep 01, 2020	CULLEN MICHAEL T.	PURCHASE	4.54	10K	45.4K	10K
Sep 01, 2020	HORVATH SUSAN	PURCHASE	4.54	2.42K	11K	2.42K
Sep 01, 2020	SIMPSON JENNIFER K.	PURCHASE	4.54	2.42K	11K	2.42K
Jun 05, 2020	SCHAFFER PAUL W.	PURCHASE	6.00	10K	60K	10K
Jun 05, 2020	HORVATH SUSAN	PURCHASE	6.00	2.5K	15K	2.5K
May 22, 2020	CULLEN MICHAEL T.	PURCHASE	4.00	10K	40K	204.58K

PBLA Stock Ownership Breakdown